Researchers at the National University of Singapore have developed a probe that provides doctors with clearer and more accurate magnetic…
Articles by Joana Fernandes, PhD
The U.S. Food and Drug Administration (FDA) approved the use of Stivarga (regorafinib) for the treatment of patients with hepatocellular…
Transplanting fecal bacteria from a healthy person to someone who has a liver-connected brain impairment may be an effective way…
Insulin resistance (IR) is associated with poorer cognitive performance and greater cognitive decline in heart disease patients with or without diabetes,…
A peptide called pNaKtide has shown promise in improving the clinical manifestations associated with non-alcoholic fatty liver disease (NAFLD) and…
Scientists have long believed that liver cancer cells needed fat molecules to survive, and that by blocking fat production, the cancer would…
Drinking coffee may reduce the risk of chronic liver disease, especially in patients with other conditions affecting the liver, including…
Combining the chemotherapy agent Sutent (sunitinib) and immunotherapy may be a promising strategy to fight hepatocellular carcinoma, the most common…
Patients with cirrhosis (liver damage) may be at a much lower risk of liver cancer than originally assumed, according to…